+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID07222787

Evaluating the Safety and Effectiveness of the CORUS-LX Device Compared to Standard Surgery for Two-Level Lumbar Fusion in Degenerative Lumbosacral Disc Disease

Led by Providence Medical Technology, Inc. · Updated on 2026-09-16

250

Participants Needed

12

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of the CORUS-LX device as an addition to lumbar interbody fusion surgery for patients with degenerative lumbosacral disc disease requiring two-level lumbar fusion at L4-S1. This study aims to determine whether the use of the CORUS-LX device improves fusion success, reduces major device-related adverse events, and decreases the need for injections or revision surgeries compared to standard minimally invasive supplemental posterior fusion. Participants will undergo two-level lumbar interbody fusion at L4-L5 and L5-S1 segments. They will be randomly assigned to receive supplemental posterior fusion using either the study device CORUS-LX with pedicle screw and rod fixation or the standard minimally invasive technique with pedicle screw and rod fixation. Both procedures involve the use of navigation technology for placing posterior instrumentation. The study includes a post-market, randomized controlled trial design with two arms the treatment arm using the study device and the control arm using the standard technique. Participants will have a screening and baseline visit, followed by surgery for their assigned intervention. After surgery, they will attend five follow-up visits at 6 weeks, 3 months, 6 months, 12 months, and 24 months. During these visits, they will complete surveys about their outcomes and undergo standard care procedures. Researchers will measure fusion success at 12 months, freedom from serious device-related adverse events, and freedom from injections or revision surgeries related to back or leg pain. The study will also explore additional outcomes such as interbody bridging bone, range of motion, and disc height changes through 24 months.

CONDITIONS

Brief Title

Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes

Research Team

M

Matt Jenkins

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here